There are new and exciting developments in the treatment of pulmonary arterial hypertension (PAH). On this episode of the ATS Breathe Easy Podcast, host Eddie Qian, MD, Vanderbilt University, sits down with Sandeep Sahay, MD, MSC, ATSF, Baylor University Medical Center, Dallas, Texas, to discuss the challenges of early diagnosis, and advances in treatment, including activin signaling inhibition with sotatercept and the potential role of new therapies. They also talk about clinical trial outcomes, balancing survival and quality of life, shared decision-making, and the future of personalized PAH treatment.
This episode is sponsored by United Therapeutics.